glp-1 new drug Weight Loss Drugs May Reduce Chance of Cancer Progressing, Study Finds GLP-1 Medications: Everything You Need

Goldstein RF, Abell SK, Ranasinha S, Misso M, Boyle JA, Black MH, et al

JiCXueGFLijunCFengPLiDLiLet al

Two pharmacoepidemiological analyses using electronic health records have reported that use of GLP-1R agonists is associated with lower rates of opioid overdose

Many lawsuits filed against Novo Nordisk allege that Ozempic users experienced severe and prolonged vomiting, delayed gastric emptying, bowel obstruction, and serious eye conditions such as anterior ischemic optic neuropathy

The comparison matters because these medications are often presented as equivalent options, and insurance formularies or provider familiarity may steer patients toward one or the other without full consideration of the differences

May 13, 2026 Articles, Diabetes, Diet & Nutrition, Exercise, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity, Therapies, Type 2 Diabetes, Type 2 Diabetes 1,239 views Losing 30 pounds may sound like an undeniable success story